Suppr超能文献

联合使用维生素C和维生素K3预处理对癌症化疗的无毒增效作用。

Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment.

作者信息

Taper H S, de Gerlache J, Lans M, Roberfroid M

机构信息

Unité de Biochimie Toxicologique et Cancérologique, Université Catholique de Louvain, Brussels, Belgium.

出版信息

Int J Cancer. 1987 Oct 15;40(4):575-9. doi: 10.1002/ijc.2910400424.

Abstract

The influence on the survival of ascitic liver tumor (TLT)-bearing mice of combined vitamins C and K3 administered before or after a single i.p. dose of 6 different cytotoxic drugs, all commonly used in human cancer therapy, was investigated. Combined i.p. administration of these vitamins produced a distinct chemotherapy-potentiating effect for all drugs examined, especially when injected before chemotherapy. This potentiating treatment did not increase the general and organ toxicity that accompanies cancer chemotherapy. The possible generation of peroxides followed by membrane lipid alteration, DNase activation and DNA destruction by combined vitamin C and K3 in catalase-deficient cancer cells might be involved in the mechanisms of this selective potentiation.

摘要

研究了在腹腔注射6种不同细胞毒性药物(均常用于人类癌症治疗)单次给药之前或之后给予维生素C和K3联合用药对荷腹水肝癌(TLT)小鼠存活的影响。这些维生素联合腹腔给药对所有检测药物均产生了明显的化疗增强作用,尤其是在化疗前注射时。这种增强治疗并未增加癌症化疗伴随的全身和器官毒性。在过氧化氢酶缺陷的癌细胞中,维生素C和K3联合用药可能产生过氧化物,继而导致膜脂质改变、DNase激活和DNA破坏,这可能参与了这种选择性增强作用的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验